Biofil Chemicals & Pharmaceuticals Ltd.
| BSE: 524396 | Sector: Health care |
| NSE: BIOFILCHEM | ISIN Code: INE829A01014 |
| BSE 00:00 | 08 Mar | 84.05 |
-4.40 (-4.97%) |
OPEN
84.05 |
HIGH
84.05 |
LOW
84.05 |
| NSE 00:00 | 08 Mar | 85.50 |
-4.50 (-5.00%) |
OPEN
85.50 |
HIGH
85.50 |
LOW
85.50 |
| OPEN | 84.05 |
| PREVIOUS CLOSE | 88.45 |
| VOLUME | 13211 |
| 52-Week high | 352.45 |
| 52-Week low | 6.55 |
| P/E | 75.72 |
| Mkt Cap.(Rs cr) | 137 |
| Buy Price | 89.00 |
| Buy Qty | 112.00 |
| Sell Price | 84.05 |
| Sell Qty | 4741.00 |
Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) - Announcements
-
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
03/03/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
24/02/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
15/02/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Intimation For Change In The Email IdS Of The Registrar And Share Transfer Agent I.E. (Ankit Consult
12/02/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Outcome Of The Board Meeting Held On 12Th February 2021
12/02/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Submission Of Un-Audited Financial Result For The Quarter And Nine Months Ended On 31St December 202
12/02/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
08/02/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
06/02/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Board Meeting Intimation for 1. To Consider And Approve The Un-Audited Financial Result Of The Compa
05/02/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Shareholding for the Period Ended December 31 2020
18/01/2021 | bse
-
Biofil Chemicals & Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended December 2020
12/01/2021 | bse
-
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08/01/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
07/01/2021 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Closure of Trading Window
30/12/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
30/12/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
29/12/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
19/12/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
18/12/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulati
05/12/2020 | bse |
Downlaod PDF -
Biofil Chemicals & Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
04/12/2020 | bse |
Downlaod PDF
Quick Links for Biofil Chemicals & Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
